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T cell activation plays a central role in immune
response and in the maintenance of self-tolerance.
We analyzed the evolutionary history of T cell regula-
tory molecules. Nine genes involved in triggering
T cell activation or in regulating the ensuing response
evolved adaptively in mammals. Several positively
selected sites overlap with positions interacting
with the binding partner or with cellular components.
Population genetic analysis in humans revealed
a complex scenario of local (FASLG, CD40LG,
HAVCR2) and worldwide (FAS, ICOSLG) adaptation
and H. sapiens-to-Neandertal gene flow (gene trans-
fer between populations). Disease variants in these
genes are preferential targets of pathogen-driven se-
lection, and a Crohn’s disease risk polymorphism
targeted by bacterial-driven selection modulates
the expression of ICOSLG in response to a bacterial
superantigen. Therefore, we used evolutionary infor-
mation to generate experimentally testable hypothe-
ses concerning the function of specific genetic
variants and indicate that adaptation to infection
underlies the maintenance of autoimmune risk
alleles.
INTRODUCTION
T lymphocytes play a central role in the elicitation of effective im-
mune responses and in the maintenance of immune homeosta-
sis. A pivotal role in T lymphocyte activation is played by the B7
family of costimulatory molecules. The best-described B7 mole-
cules, B7-1 (CD80) and B7-2 (CD86), are expressed on antigen-
presenting cells (APCs) and engage proteins belonging to the
CD28 family on the surface of T lymphocytes (Chen, 2004). Bind-
ing of either CD28 or CTLA4 by CD80 or CD86 results in immune
activation or in the dampening of immune responses, respec-tively (Chen, 2004). Among other members of the B7 family,
CD274 binds the programmed death 1 (PDCD1) receptor and
plays an important role in tolerizing and destroying self-anti-
gen-specific cells (Nurieva et al., 2009). PD-1 can bind a second
protein, PD-L2 (PDCD1LG2), on non-T cells (Nurieva et al.,
2009); this interaction suppresses human T cell activation.
Apoptosis can also be mediated by the interaction between
FAS and FASL (Strasser et al., 2009) and by the ligation of Galec-
tin-9 (LGALS9) by TIM-3 (HAVCR2). This latter belongs to the
T cell immunoglobulin mucin (TIM) family and is involved in the
inhibition of Th1 cell type immune responses (Sakuishi et al.,
2011). The interaction between Galectin-9 and TIM-3 is believed
to suppress the differentiation of naive T cells toward the Th17
cell lineage and, instead, to stimulate their differentiation into
regulatory T (Treg) cells (Sakuishi et al., 2011). Finally, the inter-
action between ICOS and ICOSL plays an important role in
cell-cell signaling and regulation of cell proliferation (Nurieva
et al., 2009), whereas the interaction between CD40 and
CD40L is central in lymphocyte activation, as well as in the regu-
lation of B cell function (Elgueta et al., 2009).
Although they represent only a subset of players in the com-
plex process of T cell regulation, the above-described proteins
have a central function in the elicitation of effective immune re-
sponses; as a consequence, several pathogens have evolved
strategies that specifically target T cell regulatory molecules to
facilitate the establishment of infection (Khan et al., 2012). There-
fore, on one hand T cell regulatory molecule genes have been
engaged in a constant conflict with pathogens and play a funda-
mental role during infections; on the other, genetic variation
within these loci has a potential impact on the development of
immunodeficiencies, autoimmune and inflammatory conditions,
and cancer.RESULTS
Widespread Positive Selection during Mammalian
Evolution
We analyzed the following genes: CD28, CD80, CD86, CD274,
CTLA4, PDCD1, PDCD1LG2, ICOS, ICOSLG, FAS, FASLG,Immunity 38, 1129–1141, June 27, 2013 ª2013 Elsevier Inc. 1129
Figure 1. Schematic Domain Representation of the Proteins Encoded by the Nine Positively Selected Genes
Selected sites identified through both BEB and MEME are shown. Positions refer to the human sequence and asterisks represent gaps in the human sequence
that correspond to positively selected residues in the alignment. The location of recombination breakpoints is also shown.
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Natural Selection at T Cell Regulatory GenesCD40, CD40LG, HAVCR2, and LGALS9 (Table S1 available on-
line). To investigate their evolutionary history in mammals, we
retrieved coding sequence information for all available species
(a list of the 39 species is available in the Supplemental Experi-
mental Procedures; see also Table S2). Multiple alignments
were analyzed to calculate the average ratio of dN (nonsynony-
mous substitution rate) to dS (synonymous substitution rate).
For most protein-coding genes, fewer nonsynonymous replace-
ments were observed compared to synonymous substitutions
(dN/dS < 1), because alterations in amino acid sequences are
more likely to be detrimental to protein function and are selected
against (purifying selection). Indeed, analysis of T cell regulatory
molecules revealed that all genes evolved under purifying selec-
tion (dN/dS < 1; Table S3). Nonetheless, positive selection
(dN/dS > 1) might act on a few sites within a gene that is globally
subject to purifying selection. To test this possibility, we applied
maximum-likelihood analyses (Yang, 2007). Specifically, we
used the codeml program to compare two models of gene evo-
lution that allow a class of codons to evolve with dN/dS > 1
against models of neutral evolution (which disallow dN/dS > 1).
Results indicated that for 9 out of 15 genes studied, the neutral
evolution models were rejected in favor of the positive selection
models (Table S2). Because recombination might yield false
positive results when likelihood-ratio tests are applied (Anisi-
mova et al., 2003), we screened the nine alignments for evidence
of recombination via GARD (genetic algorithm recombination
detection) (Kosakovsky Pond et al., 2006). PDCD1LG2, FAS,
and HAVCR2 displayed at least one recombination breakpoint
(Figure 1). Thus, we took into account both the breakpoint
locations and the domain structure for these T cell regulatory
molecules and performed the likelihood-ratio tests on gene sub-1130 Immunity 38, 1129–1141, June 27, 2013 ª2013 Elsevier Inc.regions (Figure 1). After multiple test correction (Anisimova and
Liberles, 2012), positive selection was supported by all tests
for at least one domain in each of the three genes (Table S2).
In order to identify specific sites subject to diversifying selec-
tion, we applied two methods: the Bayes empirical Bayes (BEB)
analysis (Anisimova et al., 2002) and the mixed effects model of
evolution (MEME) (Murrell et al., 2012). Only sites detected by
both methods were considered (Figure 1).
We next mapped sites targeted by diversifying selection onto
available crystal and domain structures. Analysis of CD80 (Fig-
ure 2A) indicated that three positively selected sites are located
at the CTLA4 binding interface, with one position directly inter-
acting with the MYPPPY conserved sequence of CTLA4; addi-
tional selected positions involve (Val56) or closely flank (Asp80)
sites that allow interaction between the two CD80 molecules
forming the homodimer (Figure 2A; Ikemizu et al., 2000; Stamper
et al., 2001). Analysis of the single selected site in the galectin
domain of Galectin-9 indicated that it is not directly involved in
oligosaccharide binding (Figure S1; Nagae et al., 2006). As for
the IgV domain of TIM-3, it also acts as a receptor for phospha-
tidylserine (PtdSer) (DeKruyff et al., 2010), for the alarmin
HMGB1 (Chiba et al., 2012), and for an unknown protein or
glycan (Cao et al., 2007). In analogy to other TIM family mem-
bers, PtdSer is accommodated within a pocket of the TIM-3
IgV domain (metal ion-dependent ligand binding site, MILIBS)
created by the CC0 and FG loops (DeKruyff et al., 2010); PtdSer
binding alters the structure of the tip of the CC0 loop (Figure 2C;
DeKruyff et al., 2010), and we found the two residues at the tip of
this loop to be subject to positive selection (Figure 2C). Mapping
of positively selected sites in the FAS death domain indicated
that two out of the three are located at the primary contact
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Natural Selection at T Cell Regulatory Genesinterface with FADD (Figure S1; Scott et al., 2009). As for the
tumor necrosis factor receptor (TNFR) domain, residues involved
in binding to FASL have been identified by mutagenesis (Bajor-
ath, 1999; Starling et al., 1998). Although no position directly
involved in ligand-receptor interaction was among the positively
selected sites we identified, these latter tend to cluster within a
relatively short stretch where the majority of FAS-FASL interac-
tions occur (Figure S1). Likewise, one of the selected sites in
the TNFR domain of CD40 is located at the binding interface
with CD40L (Figure 2D; An et al., 2011). Analysis of sites targeted
by diversifying selection in the cytoplasmic tail of CD40 indicated
that they occur within regions serving as binding sites for Ku,
JAK3, and TRAF6 (Morio et al., 1999; Pullen et al., 1999);
conversely, residues involved in the binding of TRAF1-3 are
highly conserved (Figure 2D; Lu et al., 2003; Pullen et al., 1999).
Finally, in the case of CD274, one of the positively selected sites
in the IgV domain flanks residues forming the PD-1 binding inter-
face (Figure 2B; Lin et al., 2008). In the case of CD86, several
positions subject to diversifying selection were identified in the
juxtamembrane (JM) and transmembrane (TM) regions (Figure 1),
which interact with the MIR2 immunomodulator encoded by
KSHV (Kaposi sarcoma-associated herpesvirus) (Kajikawa
et al., 2012). Therefore, we performed ab initio structure predic-
tion and in silico docking analysis to study the interaction be-
tween MIR2 and CD86. The structure of the CD86 JM region
was predicted to be random coil, preventing docking analysis;
conversely, the TM region was amenable to docking calculation:
this revealed that the two CD86 positively selected sites, Val260
and Trp286, are located at the contact interface of the two pro-
teins and can interact, mainly via hydrophobic contacts, with
residues of MIR2 (Figure 2E). To verify the importance of the
amino acids in positions 260 and 268, we created four different
in silico CD86 variants (Val260Ala and Trp268Ala, or Val260Gly
and Trp268Arg, these latter observed in some nonprimate mam-
mals, Figure 2E): none of them was able to bind MIR2 with the
same orientation as the human protein (Figure 2E). This analysis
confirms a crucial role of Val260 and Trp268 in the correct posi-
tioning of the two proteins during the interaction. The computed
binding poses of the variant CD86 molecules with MIR2 are un-
likely to occur in vivo, because of the presence of the phospho-
lipid bilayer (which is not explicitly considered in the docking
experiments). Therefore, these results suggest that variation at
the positively selected sites renders interaction between CD86
and MIR2 unlikely or very weak.
Local Adaptation, Balancing Selection, and Possible
Gene Flow among Archaic Hominins
We next investigated whether natural selection has affected ge-
netic diversity at T cell regulatory molecule genes in human pop-
ulations. We exploited data from the 1000 Genomes pilot project
deriving from the low-coverage whole-genome sequencing of
179 individuals with different ancestry: Europeans (CEU), Yoruba
from Nigeria (YRI), and East Asians (AS; Japanese plus Chinese)
(1000 Genomes Project Consortium et al., 2010). We calculated
the following parameters: (1) qW (Watterson, 1975) and p (Nei
and Li, 1979) describe genetic diversity and were estimated for
all T cell regulatory molecule genes (Figure S2); (2) site frequency
spectrum (SFS)-based statistics such as Tajima’s D (Tajima,
1989), normalized Fay and Wu’s H (Fay and Wu, 2000), and Fuand Li’s F* and D* (Fu and Li, 1993) were also calculated over
all genes (Table S4); (3) FST, a measure of population genetic
differentiation, was obtained for all single-nucleotide polymor-
phisms (SNPs) within T cell regulatory molecule genes (Fig-
ure S2); and (4) tests based on haplotype homozygosity (derived
intra-allelic nucleotide diversity [DIND] and integrated haplotype
score [iHS]) (Barreiro et al., 2009; Voight et al., 2006) were calcu-
lated or retrieved for all SNPs in the genes under analysis (Fig-
ure S2). The statistical significance of all tests was obtained by
deriving empirical distributions of the same parameters calcu-
lated for a randomly selected set of 1,000 genes (see Supple-
mental Experimental Procedures).
SNP genotype data from the Human Genome Diversity Panel
(HGDP) (Li et al., 2008) were also used to calculate FST values
among continental groups, haplotype homozygosity (iHS) (Sa-
beti et al., 2007), and cross population extended haplotype
homozygosity (XP-EHH) (Voight et al., 2006). Finally, measures
of the selective pressure exerted by viruses, bacteria, protozoa,
and helminths were obtained (see Experimental Procedures).
Data from the 1000 Genomes Project and from the HGDP
resource were integrated and we considered genes to represent
selection targets if they showed significant results in the same
population for at least two tests based on different features
(e.g., FST and haplotype-based tests), as previously suggested
(Manry et al., 2011).
Six genes satisfied these criteria, although closer inspection of
CD80 genetic diversity indicated that the nearby gene might
represent the selection target. CD80 showed two variants with
a significant DIND test (Figure S2) in YRI. The rationale behind
the DIND test is that a derived allele under positive selection
will display lower nucleotide diversity at linked sites than ex-
pected from its frequency in the population. Thus, the ratio of
intra-allelic diversity associated with the ancestral and derived
alleles (ipA/ipD) was analyzed against the frequency of the
derived allele (DAF) (Figure S2); given a DAF interval, a high value
of ipA/ipD suggests positive selection. One of the CD80 variants
with a significant DIND test (rs6810215, DIND = 23.24, DAF =
0.48) also had extremely high FST values (Figure S2). As noted
above, FST is a measure of population genetic differentiation: un-
der selective neutrality FST is mainly determined by demographic
history and drift, but natural selection may drive allele fre-
quencies to differ more than expected. Because selective
sweeps may involve long genomic regions, we extended the
analysis to flanking regions: a nonsynonymous variant in
TIMMDC1 (rs57168946) was in linkage disequilibrium (LD) with
the variants in CD80 (Figure S3) and showed a highly significant
DIND test (DIND = 79, DAF = 0.48), suggesting that it represents
the selection target.
ForCD274we identified five variants with significant DIND test
results in AS (Figures 3A andS2). The variant showing the highest
DIND (rs2890657) also showed an FST value higher than the 99
th
percentile in the YRI versus AS comparison (Figure S2).
rs822339, which is in LD with rs2890657 (r2 = 0.82 in AS), dis-
played a significant correlation with the diversity of bacteria
(rank = 0.96). We performed haplotype analysis over an
extended genomic interval encompassing CD274 (Figure S3).
Within this region, no SNP displayed a DIND test higher than
rs2890657, and only one (rs10815233) had a higher FST. Overall,
these data indicate that a homogeneous haplotype increased inImmunity 38, 1129–1141, June 27, 2013 ª2013 Elsevier Inc. 1131
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Figure 2. Analysis of Positively Selected Sites
In all panels positively selected sites are shown in red.
(A) Ribbon diagram of the extracellular regions of CD80 (light gray) and CTLA4 (dark gray). Residues involved in the CD80-CTLA4 interaction are represented in
yellow on both proteins; positions involved in the interaction between the twoCD80monomers are in blue. Positions in green indicate positively selected sites that
(legend continued on next page)
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Natural Selection at T Cell Regulatory Genesfrequency in AS (Figure S3), possibly because of the selective
pressure exerted by bacterial pathogens, and suggest that
rs2890657 represents a selection target. This SNP is located in
a region characterized by H3K4Me1 and H3K27Ac histone
marks and by the binding of RNA polymerase II, as determined
by chromatin immunoprecipitation and sequencing (ChIP-seq)
(Figure 3A).
CD40LG showed very low diversity in CEU and tended to
display low p in AS (Figure S2); in this latter population, Tajima’s
D and Fay and Wu’s H displayed significantly low values (Table
S4). These features are suggestive of a selective sweep. In
fact, the increase in frequency of a selected haplotypemay result
in a temporary reduction in the level of genetic variability and in a
shift of the SFS, leading to a deficiency of intermediate frequency
alleles (negative values of Tajima’s D or Fu and Li’s D* and F*).
Also, a selective sweep may determine an excess of high-fre-
quency derived alleles (negative values of Fay and Wu’s H).
FST analysis of CD40LG indicated that rs3092923 had a value
higher than the 95th percentile in both YRI versus CEU and YRI
versus AS comparisons (Figure S2). Another variant in CD40LG
(rs3092936) was an outlier in the distribution of FST values calcu-
lated for continental groups in the HGDP, an effect mainly driven
by populations in the Americas (Figure 3B). Therefore, we per-
formed haplotype analysis over an extended region with the in-
clusion of the 1000 GenomesMain Project data, which comprise
Native American populations (Figure S3). Two variants in the re-
gion, rs3092923 and rs3092921, had extremely high FST (YRI
versus AS). The former was located at the end of intron 4, a re-
gion where a T-cell-lineage-specific enhancer has been
described (Schmidl et al., 2009), and the region surrounding
rs3092923 displayed H3K4me1 histone marks (Figure 3B). In
Native Americans a second extended haplotype carried the
derived allele of rs3092936 plus several additional derived alleles
(Figures 3B and S3). These define a haplotype with a frequency
of 27% in Native Americans and near absence in Africa, Europe,
and Asia. To identify the putative selection target(s), we calcu-
lated AS versus American FST for all variants in the region: the
originally identified rs3092936 together with nine additional
SNPs had the highest FST (0.153) and the ten variants displayed
the same DAF of 0.27 in Americans. Three of these SNPs fall
within noncoding sequences that are highly conserved in mam-
mals (Figure 3B).
ForHAVCR2, we identified two variants with a significant DIND
test in YRI (Figure S2); one of these SNPs (rs4704846) also dis-
played extreme FST values in the YRI versus AS comparison (Fig-also represent positions directly involved in CTLA4 binding or in CD80-CD80 int
CTLA4.
(B) Structure of CD274 extracellular domain; residues in yellow directly interact w
(C) Surface of the TIM-3 IgV domain bound (left) or unbound (right) to PtdSer. Res
are involved in the binding of an unknown cellular component. The alignment for
species. Color codes are the same as in the surface model; four cysteines conse
(D) Ribbon diagram of the TNFR domain of CD40 and alignment of the CD40 cytop
to CD40L. The green residue is positively selected and involved in CD40L bindin
(E) Structures of CD86 andMIR2. Left: docked structures of CD86 (blue) and MIR2
in protein-protein interaction, are shown as yellow and orange spheres, respect
resented as sticks. Middle: docked structures of human CD86 (black) and four d
Trp268Arg (orange). Right: MIR2 interacting sites and alignment of the JM and T
position 244 is in blue.
See also Figure S1.ure S2), whereas the other (rs11741184) had a significant iHS
score (iHS = 2.037) in Africans. The iHS test is similar in
concept to the DIND test and is based on haplotype homozygos-
ity. Analysis over an extended region (Figure S3) indicated that
no variant has higher DIND or FST than rs4704846. This variant
falls in the 30 UTR, within a predicted binding site for miR-379
(http://www.microrna.org/microrna), and replaces a G-C
pair to a G-U wobble (Figure 3C). Two HAVCR2 variants
(rs61159436 and rs6886320) significant at the DIND test were
also identified in AS (Figure S2), and in this population low values
of Fu and Li’s D* and F* were observed (Table S4). rs61159436
had the highest DIND test in the analyzed region and is located
in the fifth intron of HAVCR2 (Figure 3C).
FAS showed high diversity in AS and CEU populations (Fig-
ure S2), and several SFS-based statistics were significantly
high in these same populations (high values of Tajima’s D or Fu
and Li’s F* and D* suggest balancing selection) (Table S4). Addi-
tionally, we detected six variants with extreme FST values in the
CEU versus YRI comparison (Figure S2) and located in the 50
portion of intron 1 (Figure 4A); one variant in this region
(rs7097467) was found to significantly correlate with helminth di-
versity (rank = 0.96). These features might suggest the action of
balancing selection in the 50 gene region. Signatures of balancing
selection tend to be elusive, because no extended haplotype is
expected under this selective regime. Therefore, we performed
Sanger-resequencing and coalescent simulations to test for se-
lection. We sequenced a 5 kb region encompassing the FAS
core promoter and first exon (Figure 4A). Results confirmed
very high nucleotide diversity in CEU and AS, as well as high
values for SFS statistics especially in CEU (Table 1). Under
neutral evolution, the amount of within-species diversity corre-
lates with between-species divergence, because both depend
on the neutral mutation rate. This comparison is formalized in
the Hudson-Kreitman-Aguade` (HKA) test (Hudson et al., 1987).
We performed a maximum likelihood HKA test (MLHKA): for all
populations, MLHKA rejected the null model of selective
neutrality and an excess of polymorphism compared to diver-
gence was detected (Table 1). Haplotype analysis identified
two major clades (A and B) (Figure 4B), and calculation of the
time to the most recent common ancestor (TMRCA) resulted in
estimates ranging from 3.75 to 2.03 My (Table S5). Analysis of
variants in the haplotype network indicated that rs1800682
(670 A>G) separates the two major clades (Figure 4B); this
variant affects a signal transducer and activator of transcrip-
tion-1 (STAT1) binding site (Kanemitsu et al., 2002) anderactions. The insert shows the CD80 surface involved in the interaction with
ith PD-1. Residue 93 is not visible in this image (back surface).
idues 35 and 39 are not visible in this model (back surface). Residues in yellow
a portion of the IgV domain is also shown for a few representative mammalian
rved in all TIM genes are shown in blue.
lasmic domain. The yellow residues in the TNFR domain are involved in binding
g. On the alignment, the binding sites for Ku, JAK3, and TRAFs are shown.
(green). The human CD86 amino acids Val260 and Trp268, which are involved
ively. The residues of MIR2 that interact with these two amino acids are rep-
ifferent variants: Val260Ala (fuchsia), Val260Gly (green), Trp268Ala (blue), and
M regions of CD86 for a few representative mammals; the aspartic residue at
Immunity 38, 1129–1141, June 27, 2013 ª2013 Elsevier Inc. 1133
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Figure 3. Analysis of Selected Variants
Location of the most likely selection targets in CD274 (A), CD40LG (B), HAVCR2 (C), and FASLG (D) within the UCSC Genome Browser view. Relevant ENCODE
tracks are also shown. Variants in blue and magenta represent selection targets in YRI and AS, respectively. Polymorphisms in black represent selected sites in
Native Americans (B) and those in green fall within PhastCons elements. See also Figure S3.
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(Farre et al., 2008). The helminth-selected variant defined a sub-
group of haplotypes in clade A (Figure 4B). Overall, these data
are consistent with a model of multiallelic balancing selection.1134 Immunity 38, 1129–1141, June 27, 2013 ª2013 Elsevier Inc.Finally, PDCD1 was found to display very high nucleotide
diversity in AS populations (Figure S2). FST analysis indicated
that several variants with extreme values in the CEU versus AS
comparison are located both in the 50 and 30 gene regions;
AB
C D
E F
Figure 4. FAS and PDCD1 Analysis
(A) Exon-intron structure of FAS with the location
of FST outliers (red dots). The region we re-
sequenced is delimited by the red hatched lines.
(B) Genealogy of haplotypes in the sequenced
region reconstructed through a median-joining
network. Each node represents a different haplo-
type, with the size of the circle proportional to
frequency. Nucleotide differences between hap-
lotypes are indicated on the branches. Variants
with extreme FST and correlating with helminth
diversity are shown in red and green, respectively.
The position of rs1800682 (blue), which affects
STAT1 binding, is shown.
(C) Exon-intron structure of PDCD1; resequenced
regions are delimited by hatched lines.
(D) Blocks of LD for the two resequenced regions
(AS haplotypes only). Cyan and gray denote po-
sition matching the Neandertal sequence and not
covered in Neandertal, respectively; the ancestral
state and Denisova sequences are also shown.
(E) GENETREE for the LD subregion of PDCD1.
Variants are represented as black dots; the ab-
solute frequency of each haplotype is reported.
(F) Network analysis of extant haplotypes with the
Denisova (yellow) and Neandertal (cyan) se-
quences. The network was constructed for a 30.5
kb region after discarding positions where either
the ancestral state could not be inferred or the
Denisova and Neandertal genomes were not
covered. Haplotypes occurring only once were
also discarded for network construction.
See also Figure S4.
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(Figures 4C and S2). Calculation of qW and p confirmed high
nucleotide diversity in AS and high Tajima’s D in this population
(Table 1). Conversely, in CEU and YRI diversity was not excep-
tional and several SFS statistics tended to be low (Table 1).
Haplotype analysis revealed two major clades, one of which (N
clade) was almost specific to Asians and matching the Nean-
dertal sequence in all positions (seven derived, three ancestral)
where the hominin sequence is covered (Figure 4D). We esti-
mated a coalescence time of 602,298 years for the whole haplo-
type phylogeny and similar TMRCAs of 344,827 and 445,623
years for clade N and non-N haplotypes, respectively. A more
robust TMRCA estimate was calculated with GENETREE over
a shorter region of LD (Figure S4) and yielded comparable results
(Figure 4E). Calculation of p for Asian chromosomes gave esti-
mates of 3.553 104 and 6.523 104 for the N and non-N clade,Immunity 38, 1129–114respectively. To gain further insight,
we retrieved human haplotypes for a
30 kb region centered around PDCD1.
For each polymorphic position, we deter-
mined the ancestral state (from at least
two primate genomes) and the status in
the two Neandertal and Denisova ge-
nomes. A median-joining network indi-
cated that the Neandertal and Denisova
sequences cluster with N and non-N hap-
lotypes, respectively (Figure 4F). Finally,we calculated the extended haplotype homozygosity (EHHA)
over a 200 kb region: a similar EHHA plot was obtained for the
two alleles of a variant tagging the N and non-N haplotypes
(Figure S4).
Natural Selection Shaped Allele Frequencies at Disease
Variants
To study the selective patterns of disease SNPs in T cell regula-
tory molecule genes, we focused on variants that have been
identified through genome-wide association studies (GWASs).
A total of 20 GWAS variants were retrieved. Out of these, 13
SNPs were available in the HGDP-CEPH panel and 7 correlated
with the diversity of at least one pathogen species (Table 2).
Although some of these seven variants are located relatively
close to each other, LD among SNPs pairs is relatively low (r2
not exceeding 0.8 in either CEU, YRI, or AS), suggesting that1, June 27, 2013 ª2013 Elsevier Inc. 1135
Table 1. Nucleotide Diversity and Neutrality Tests for Sanger-Sequenced Regions
Gene Lc Popd Se
qW
a pb Tajima’s D Fu and Li’s D* Fu and Li’s F* MLHKA
Value Rankf Value Rankf Value pg Value pg Value pg Kh pi
FAS 5.4 YRI 31 13.48 0.89 9.95 0.74 0.90 0.34 1.08 0.02 0.47 0.11 3.17 00042
CEU 30 13.05 0.95 21.73 0.98 2.29 0.01 1.29 0.04 1.94 0.01 4.17 0.00027
AS 31 13.48 0.97 21.21 0.98 1.98 0.03 0.11 0.45 0.89 0.19 5.13 0.00014
CTLA4 2.4 YRI 21 21.19 0.98 26.20 0.99 0.79 0.049 0.74 0.07 0.89 0.041 2.64 0.026
CEU 15 14.45 0.98 22.85 0.98 1.85 0.028 1.56 0.009 1.95 0.0074 2.31 0.079
AS 12 11.56 0.95 14.90 0.94 0.89 0.23 0.05 0.45 0.30 0.42 2.10 0.095
ICOSLG 2.4 YRI 21 20.42 0.98 18.40 0.97 0.33 0.62 0.68 0.12 0.41 0.16 3.34 0.0045
CEU 17 16.53 0.98 31.96 >0.99 3.03 <0.001 1.60 0.0018 2.45 <0.001 3.68 0.0061
AS 19 18.47 0.99 35.09 >0.99 2.96 0.0017 1.29 0.05 2.18 0.0026 4.53 0.00083
PDCD1 4.3 YRI 22 12.04 0.81 8.23 0.61 1.06 0.24 2.46 0.025 2.35 0.035 0.82 0.09
CEU 20 10.95 0.91 7.98 0.76 0.90 0.15 2.82 0.021 2.57 0.028 1.15 0.18
AS 21 11.49 0.95 19.12 0.98 2.21 0.02 0.35 0.35 1.15 0.1 1.51 0.34
See also Figure S2.
aqw estimation per site (310
4).
bp estimation per site (3104).
cLength of analyzed resequenced region (in kb).
dPopulation (YRI, Yoruba; CEU, European; AS, Asian).
eNumber of segregating sites.
fPercentile rank relative to a distribution of 238 5 kb windows from NIEHS genes.
gp value obtained from coalescent simulations.
hSelection parameter (k > 1 indicates an excess of polymorphism compared to divergence).
ip value for the MLHKA test.
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events. We evaluated the probability to obtain a similar number
of pathogen-selected variants by applying a resampling
approach (Supplemental Experimental Procedures). Results
indicated that disease variants in T cell regulatory molecule
genes are preferential targets of pathogen-driven selection (p =
0.013).
Analysis of the seven variants indicated that in six cases (i.e.,
for all autoimmune diseases), the susceptibility allele was asso-
ciated with higher pathogen diversity (Table 2); in the case of IgA
deficiency, the opposite situation was observed, with the sus-
ceptibility allele having higher frequency in regions where path-
ogen load is lower.
Pathogen-driven variations in allele frequencies can occur un-
der different selective scenarios such as directional or balancing
selection. Therefore, we calculated FST and performed the DIND
test for disease variants and estimated SFS-based statistics in 5
kb windows around each disease SNP.
The two variants in FASLG that correlate with pathogen diver-
sity also showed a significant DIND test in AS (Table S6), very
high DAF in this population, and extreme FST values (Table S6).
These two SNPs lie in the large intergenic spacer separating
FASLG from TNFSF18 and analysis of the HDGP data indicated
that this region showed significantly high XP-EHH and iHS
scores in East Asia and America. Haplotype analysis in AS
showed that many variants in a large genomic region covering
the intergenic spacer had extreme FST values (Figure 3D).
Several of these SNPs cluster in a region where histone marks
associated with transcriptional enhancers have been described
and some fall within ChIP-seq-identified transcription factor
binding sites (Figure 3D).1136 Immunity 38, 1129–1141, June 27, 2013 ª2013 Elsevier Inc.The rs231735 variant associated with rheumatoid arthritis (RA)
(Table 2) is located upstream the transcription start site of
CTLA4. Given the high values for both qw and p in most popula-
tions and the positive SFS-based statistics in YRI and CEU
(Table S7), we Sanger-resequenced a 2.5 kb region centered
around the variant. qw and p values higher than the 95
th were
confirmed in YRI and CEU (Table 1); the MLHKA test revealed
a significant excess of polymorphism over divergence in YRI
(borderline in CEU, Table 1). In non-Asian populations, simula-
tions indicated significantly high results for most SFS-based sta-
tistics (Table 1), and the estimated TMRCA for the haplotype
phylogeny ranged from 2.84 to 1.9 My (Table S5). Overall, these
data support the action of balancing selection on this region in
African populations and possibly in CEU. The RA risk variant
that correlated with helminth and bacteria diversity (Table 2) sep-
arates the two major haplotype clades (Figure 5A). Interestingly,
another SNP (rs6715389) on the major branch fell within a
sequence that is conserved in mammals and changes an almost
invariant position, suggesting that it might represent the
balancing selection target (Figure 5A).
Finally, for ICOSLG, two risk SNPs (rs762421, which strongly
correlates with bacterial diversity, and rs2838519) for inflamma-
tory bowel disease (IBD) are located downstream the transcrip-
tion end site in close proximity to each other. Resequencing of
the interval encompassing the two disease variants confirmed
(Table S7) high diversity in all populations and significant MLHKA
results were obtained (Table 1). In CEU and AS most SFS-based
statistics were significantly higher than expected under neutrality
(Table 1). Thus, the region carrying the two IBD risk variants rep-
resents a balancing selection target. Haplotype analysis re-
vealed a genealogy (TMRCA 4.37–2.39 My, Table S5) with two
Table 2. Correlations with Pathogen Diversity for SNPs Associated with Different Traits
GWAS SNP
Risk
Allele Trait Gene or Region
Virus Diversity Bacteria Diversity Protozoa Diversity Helminth Diversity
p Valuea Rankb p Valuea Rankb p Valuea Rankb p Valuea Rankb
rs231735 T* rheumatoid
arthritis
intergenic (CD28,
CTLA4)
>0.05 0.79 1.8 3 104 0.95 >0.05 0.73 9.3 3 109 1.00
rs1024161 T* Graves’ disease;
alopecia areata
intergenic (CD28,
CTLA4)
>0.05 0.76 2.3 3 104 0.87 5.2 3 104 0.90 8.3 3 106 0.98
rs762421 G* Crohn’s disease intergenic (ICOSLG) >0.05 0.75 7.7 3 107 0.99 >0.05 0.73 3.7 3 103 0.80
rs9282641 G* multiple sclerosis Intronic or UTR (CD86) 4.1 3 104 0.98 >0.05 0.42 1.9 3 105 0.96 6.8 3 104 0.87
rs2234978 A IgA deficiency exonic, synonymous
(FAS)
>0.05 0.78 1.2 3 106 0.98 1.0 3 105 0.97 1.4 3 104 0.93
rs859637 A* celiac disease intergenic (FASLG) >0.05 0.68 4.3 3 106 0.97 9.4 3 104 0.89 4.1 3 105 0.97
rs9286879 G* Crohn’s disease intergenic (FASLG) >0.05 0.73 5.3 3 106 0.96 8.9 3 104 0.89 2.0 3 105 0.97
NOTE: the risk allele is denoted with an asterisk if it positively correlates with pathogen diversity (i.e., the frequency of the risk allele increases with
pathogen diversity).
ap values are Bonferroni corrected for 13 tests.
bPercentile rank of tau relative to the distribution of SNP control sets matched for allele frequency.
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Natural Selection at T Cell Regulatory Genesmajor clades (A and B) (Figure 5B). Most haplotypes in clade B
carry both risk alleles for IBD. We next evaluated the induction
of ICOSLG mRNA after Staphylococcal enterotoxin B (SEB)
treatment in peripheral blood mononuclear cells (PBMCs) from
18 healthy volunteers with different rs762421 genotype (six indi-
viduals for each genotype). A significant difference in ICOSLG
induction was observed among the three genotype groups
(one-way ANOVA, p = 0.043) with the C allele (which confers
increased risk for CD and correlates with bacterial diversity)
determining higher expression (Figure 5C). On average, SEB in-
duction led to a 2.5-fold higher ICOSLG expression in PBMCs
from subjects homozygous for the C allele compare to T homo-
zygotes (t test, two-tailed, p = 0.033).
DISCUSSION
Evolutionary analyses can provide information on the location
and nature of adaptive changes in genomic regions, highlighting
the presence of functional variation. We aimed at providing a
comprehensive analysis of T cell regulatory molecule gene evo-
lution, although we stress that those we analyzed herein by no
means represent thewhole set of molecules involved in the regu-
lation of T cell activity. We show that the majority (9 out of 15) of
T cell regulatory molecule genes have been targeted by positive
diversifying selection in mammals. Notably, some genes that
were not positively selected in mammals represented selection
targets during the recent evolutionary history of human popula-
tions and carry selected alleles associated with autoimmune dis-
eases (e.g., ICOSLG and FASLG). This may reflect not only the
variability of selective pressures and the different time spans
involved but also the availability of different methods to study
evolutionary processes at the inter- and intraspecific level. At
both levels, infectious agents may have represented a powerful
selective force acting on T cell regulatory molecules. Pathogens
either may develop strategies to modulate the transcription of
these genes (Khan et al., 2012) or they may encode molecules
that directly bind T cell regulatory molecules and alter their func-
tion. Also, T cell regulatory molecules may be commonly ex-
ploited as receptors by viruses (Dermody et al., 2009). Indeed,the IgV domains of several proteins are used as viral receptors;
in these cases the viral components invariably engage sites in
the CC0FG b sheet of the immunolglobulin fold (Dermody et al.,
2009). Residues Val60 and Phe61 in TIM-3 and Val56 in CD80
occur on the CC0 b strand (Ikemizu et al., 2000) of the IgV domain,
whereas position 51 in CD274 immediately flanks the C strand
(La´za´r-Molna´r et al., 2008). Thus, these sites might have evolved
to avoid recognition by some extant or extinct viral species. The
hypothesis that diversifying selection at T cell regulatory mole-
cule genes is at least partially virus driven was tested more
directly for CD86. Indeed, the KSHV MIR2 ubiquitinase directly
binds CD86 through its JM and TM regions (Kajikawa et al.,
2012). Docking analysis indicated that the two positively
selected sites in the TM region of CD86 are crucial for the inter-
action with MIR2. Therefore, the selective pressure exerted by
MIR2 might have driven the evolution of the CD86 TM region to
decrease binding by viral-encoded ubiquitinases or to displace
the ubiquitine ligase domain from its targets in the cytoplasmic
domain of CD86. Interestingly, MIR2-like proteins are encoded
by other herpesviruses and poxviruses, suggesting that they
represent a conserved viral mechanisms to control the host im-
mune response (Mansouri et al., 2003).
Several positively selected sites we identified are very close to
or overlap with positions directly involved in interactions with the
binding partner or with cellular components. In TIM-3, two of the
positively selected sites at the top of the CC0 loop rim the pocket
that accommodates PtdSer, a central signal exposed by
apoptotic cells and exploited by intracellular pathogens to
dampen the host response (Wanderley and Barcinski, 2010).
Substitution of the mouse residues at the top of the CC0 loop
of TIM-3 (WSQ) with the corresponding human amino acids
(VFE) significantly decreases PtdSer binding (DeKruyff et al.,
2010), providing direct evidence that positive selection at these
sites affected the functional properties of TIM-3. Experiments
in mice have recently shown that the MILIBS is also important
for the interaction with the alarmin HMGB1 (Chiba et al., 2012).
Thus, it will be interesting to evaluate whether the positively
selected sites affect the efficiency of TIM-3 binding to HMGB1.
We also detected several positively selected sites in theImmunity 38, 1129–1141, June 27, 2013 ª2013 Elsevier Inc. 1137
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Figure 5. CTLA4 and ICOSLG Analysis
(A) Median-joining network for haplotypes in the
region surrounding rs231735 (RA susceptibility
variant). The position of rs231735 is shown, aswell
as the position and multiple alignment for
rs6715389.
(B) Genealogy of haplotypes in the region en-
compassing rs762421 and rs2838519 (down-
stream ICOSLG).
(C) Analysis of ICOSLG expression after stimula-
tion of PBMCs with SEB. ICOSLG abundance is
shown as fold-change expression from the un-
stimulated sample. Mean values ± standard errors
are shown.
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Natural Selection at T Cell Regulatory Genesextracellular JM regions of PD-L2 and CD274 and one in the JM
portion of CD40. The corresponding ‘‘stalk’’ regions of TNF re-
ceptors modulate the responsiveness to the soluble but not to
themembrane-bound form of TNF (Richter et al., 2012), suggest-
ing that the JM regions of the PD-1 receptors and CD40 might
play still unknown relevant functions. Indeed, CD40 belongs to
the TNFR family and signals through both a membrane-bound
and a soluble form of CD40L. The three positively selected sites
in CD28 are located in the TM domain; this region could contain1138 Immunity 38, 1129–1141, June 27, 2013 ª2013 Elsevier Inc.signals that modulate the association of
CD28 with lipid rafts, as demonstrated,
for example, for the TM domains of
CD40 and FcgRIIA (Bock and Gulbins,
2003; Garcı´a-Garcı´a et al., 2007).
T cell regulatory molecules have been
the subject of extremely intense
research. Data herein suggest caution
when extrapolating results from specific
experiments in model organisms,
because a considerable portion of ge-
netic diversity at these genes has accu-
mulated not as a result of neutral pro-
cesses but in response to adaptive
events. As such, several interspecific
changes are expected to entail functional
effects, as shown in the case of the hu-
man and mouse TIM-3 orthologs.
Data herein indicate that adaptive
change has also played a relevant role
in shaping T cell regulatory molecule
gene diversity in human populations. All
the selective events we identified in hu-
mans target noncoding variants. In addi-
tion to the functional FAS polymorphism,
we determined that the putativeHAVCR2
selection target is located in the 30 UTR
and affects a predicted binding site for
miR-379. This microRNA is downregu-
lated after CD4+ T cell exposure to
HIV-1 antigens (Bignami et al., 2012),
and expression of TIM-3 defines a popu-
lation of exhausted T cells in chronic
HIV-1 infection (Sakuishi et al., 2011). In
general, TIM-3 has a crucial role in thedevelopment of T cell exhaustion in other chronic viral infections
such as HCV (Sakuishi et al., 2011), suggesting that it might be
targeted by several pathogens as a strategy to downmodulate
host response.
A likely regulatory role on gene expression can also be envis-
aged for the putative selection target in CD274, as well as for the
variants defining the CD40LG and FASLG selected haplotypes.
The signatures we detected at these loci were mainly geograph-
ically restricted and in the case of CD274 and FASLG we found
Immunity
Natural Selection at T Cell Regulatory Genesthe selected variants to correlate with pathogen diversity, sug-
gesting that they might confer resistance to one or more infec-
tious agents. In fact, different pathogens, including mycobacte-
ria, Helicobacter pylori, and HIV-1, upregulate the expression of
CD274 to dampen or evade the host immune response (Khan
et al., 2012). Signatures of local adaptation were also detected
atPDCD1 and haplotype analysis revealed that the detected sig-
natures are accounted for by the presence of a haplotype clade
that shares many alleles with the Neandertal sequence. Nean-
dertals and Denisovans are genetically more similar to contem-
porary European and Asian populations than to Africans (Green
et al., 2010; Reich et al., 2010), and gene flow from archaic
hominins to humans occurred at other loci, including STAT2
and HLAB (Abi-Rached et al., 2011; Mendez et al., 2012). Anal-
ysis of the PDCD1 region indicates that: (1) the TMRCA of the
N and non-N clades are similar and much deeper than the time
when introgression is expected to have occurred (37,000 to
86,000 years ago) (Sankararaman et al., 2012); also, the TMRCA
of the whole genealogy is relatively recent; (2) nucleotide diver-
sity is lower for N compared to non-N haplotypes but not dramat-
ically so, whereas strong reduction of diversity would be
expected for a recently acquired haplotype; and (3) the LD
pattern is not unusual and the N and non-N haplotypes have
similar haplotype homozygosity. We note that TMRCA infer-
ences should be taken with caution, and no extensive LD might
be expected in a subtelomeric region, where PDCD1 is located.
Nonetheless, these observations do not support the Neandertal-
to-human introgression hypothesis for PDCD1. However, intro-
gression may have occurred from human populations to Nean-
dertals (in line with the observation that the Neandertal and
Denisova sequences are quite divergent in the region we
analyzed). In this case, humans would contribute genomic re-
gions that are expected to have TMRCAs solely dependent on
human history. Thus, balancing selection might have maintained
the two PDCD1 haplotype clades in Asian populations, due to
some local selective pressure, and the N haplotype might have
introgressed Neandertal populations through hybridization. It is
presently impossible to establish how gene flow occurred (e.g.,
a single episode, multiple episodes, or continuous gene flow)
(Sankararaman et al., 2012).
We also addressed the question of whether adaptive events at
T cell regulatory molecule genes have affected the spread of hu-
man disease alleles. We found variants for human diseases to be
preferential targets of pathogen-driven selection. The disease
variants we describe herein as selection targets are located in
noncoding regions, in line with regulation of gene expression be-
ing a major determinant of phenotypic variation and a common
target of adaptive evolution (Lappalainen and Dermitzakis,
2010). Specifically, our data show that, whereas all autoimmune
risk alleles correlate positively with pathogen diversity, the oppo-
site situation is observed for IgA deficiency, suggesting that (1)
risk alleles for autoimmunity confer higher protection against in-
fections, and (2) their spread in human populations results from
adaptation. We provided a demonstration of (1) by showing
that the IBD risk allele (rs762421), which correlates with bacterial
diversity, indeed increased the expression of ICOSLG mRNA in
response to a bacterial superantigen. Moreover, the observation
that the IgA deficiency allele is more common where pathogen
load is low supports the validity of our approach, becauseIgA-deficient subjects are more susceptible to recurrent bacte-
rial infections and to giardiasis (Yel, 2010). As for the second
point, three out of seven variants displaying signatures of path-
ogen-driven selection are located in nonneutrally evolving re-
gions, as assessed by different tests. Therefore, these data
expand previous observations (Fumagalli et al., 2009; Zherna-
kova et al., 2010) indicating adaptation to infection as the under-
lying explanation for themaintenance of a set of autoimmune risk
alleles in human populations.
EXPERIMENTAL PROCEDURES
Evolutionary Analysis in Mammals
Most mammalian sequences were retrieved from the Ensembl website (http://
www.ensembl.org/index.html). The chimpanzee sequences for CD40 and
PDCD1 were reconstructed through BLAST search of Trace Archives and
sequencing of a Pan troglodytes individual (see below), respectively. DNA
alignmentswere performedwith the RevTrans 2.0 utility (Wernersson and Ped-
ersen, 2003). Alignment uncertainties were removed by trimAL (automated1
mode) (Capella-Gutie´rrez et al., 2009). We selected models of amino acid sub-
stitution and constructed phylogenetic trees with ProtTest3 (Abascal et al.,
2005). GARD and MEME analyses were performed through the DataMonkey
sever (http://www.datamonkey.org). Further details on evolutionary analyses
are given in Supplemental Experimental Procedures.
DNA Samples, Sequencing, and Population Genetic Analyses
Human genomic DNA from HapMap subjects (20 Yoruba [YRI], 20 European
[CEU], and 20 Asians [AS]) was obtained from the Coriell Institute for Medical
Research. The genomic DNA of a Pan troglodyteswas obtained from the Gene
Bank of Primates, Germany. Details on Sanger sequencing and on the analysis
of the Neandertal and Denisova sequences are available as Supplemental
Experimental Procedures. Data from the Pilot 1 phase of the 1000 Genomes
Project were retrieved from the dedicated website (http://www.
1000genomes.org/) (1000 Genomes Project Consortium et al., 2010). All de-
tails on population genetic analyses are available in Supplemental Experi-
mental Procedures.
HGDP-CEPH Panel Data and Pathogen-Driven Selection
FST was calculated for all HGDP-CEPH variants among continental groups; FST
distributions were calculated for MAF (minor allele frequency)-matched SNP
classes; outliers were defined as variants with an FST higher than the 95
th
percentile in the distribution of SNPs in the same MAF class.
The approach used to identify variants selected by different pathogen spe-
cies has been described elsewhere (Fumagalli et al., 2009) and is briefly sum-
marized in the Supplemental Experimental Procedures. We considered a SNP
to be significantly associated with pathogen diversity if it displayed a signifi-
cant correlation and a t rank higher than 0.95.
SEB Stimulation and ICOSLG Transcript Quantification
Peripheral blood mononuclear cells (PBMCs) from 18 volunteers (age 22–28
years) were stimulated with SEB; quantification of the ICOSLG and GAPDH
transcripts was performed by real-time PCR (Supplemental Experimental Pro-
cedures). The study was reviewed and approved by the institutional review
board of the Scientific Institute IRCCS E. Medea.
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